WALTHAM, Mass. and GLEN ROCK, N.J., March 17 DecisionResources, Inc., one of the world's leading research and advisory firmsfocusing on healthcare insights and analysis, announced today that it acquiredFingertip Formulary, the leading provider of access to and insight intoformulary data in the United States. The acquisition of Glen Rock, NJ-basedFingertip Formulary by Waltham, MA-based Decision Resources, Inc. will resultin a significant expansion of Decision Resources, Inc.'s current managed carefranchise.
Fingertip Formulary's focus on data, delivery and diligence has set thecompany apart in the industry.
"We are excited to begin our next phase of growth with Decision Resources,Inc.," said Paul Greenberg, M.D., president of Fingertip Formulary. "FingertipFormulary's high quality formulary data, combined with our innovative web-based, real-time delivery solutions and our constant focus on the highestquality customer service has allowed us to become a premier provider formanaged care data and services to the pharmaceutical industry. As part of theDecision Resources, Inc. family, we will continue our quality work and lookforward to expanding our solutions."
Offering a Bridge to Pharmaceutical Brand Managers to Connect Health Planswith Formulary Status, Prescription Drug Utilization and Prescribing Trends
Fingertip Formulary maintains the highest quality and most comprehensive,integrated database of formulary information in the United States, coveringvirtually all commercial, Medicare, Medicaid and PBM plans. The company'sservices allow pharmaceutical executives, including brand teams and salesprofessionals, to leverage managed care formulary information as a significantand competitive advantage.
"Pharmaceutical brand managers must devote significant time to the managedcare environment as reimbursement dictates a large part of their drug'ssuccess," said Shahir Kassam-Adams, Chief Strategy Officer, DecisionResources, Inc. "Fingertip Formulary adds an important component to theDecision Resources, Inc. strategic portfolio. The best-in-class formularyinformation and analytics will make it possible for us to continue buildingout a fully integrated pharmaceutical market-access solution."
Targeted Acquisition Part of Decision Resources, Inc.'s Overall GrowthStrategy
The acquisition is part of an aggressive growth strategy by DecisionResources, Inc. Decision Resources, Inc.'s current business units includeHealthLeaders-InterStudy, which provides managed care insight, MillenniumResearch Group, which provides medical device market research, DecisionResources, which provides biopharmaceutical market analysis and AMR, ArlingtonMedical Resources, which provides data and insights into the usage of anti-infective drugs within the hospital setting and the worldwide practice ofdiagnostic imaging. The addition of Fingertip Formulary to the stable ofDecision Resources, Inc. companies will allow for significant cross-businessunit opportunities.
"Fingertip Formulary is an important acquisition in Decision Resources,Inc.'s overall strategy to grow and strengthen our portfolio with firmsfocusing on high quality research and analysis of the healthcare market," saidPeter Hoenigsberg, CEO of Decision Resources, Inc. "By targeting best-in-classfirms with a leading position in a particular area of the industry, DecisionResources, Inc. has been able to build a significant collection of companiesthat address the specific needs of our clients. Fingertip Formulary bringswith it an impressive client-base and sophisticated employees dedicated todelivering the most accurate, comprehensive formulary product on the markettoday."
Fingertip Formulary will remain headquartered in Glen Rock, NJ.
About Fingertip Formulary(R)
Fingertip Formulary (http://www.FingertipFormulary.com) offerscomprehensive formulary data